Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

January 2, 2024

Sudo raises $116M to develop TYK2 inhibitors for MS, other diseases

  • Misc. Research Reports
    /
  • MS Drug Therapies
    /
 Biopharmaceutical plans to advance 2 candidates into clinical trials in 2024 by Patricia Inacio, PhD | January 2, 2024 Sudo…
Misc. Research Reports

December 27, 2023

Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy

  • MS Research Study and Reports
    /
  Abstract Background: After natalizumab discontinuation severe relapses can occur despite pregnancy, but third trimester exposure is associated with neonatal haematological…
MS Research Study and Reports

December 22, 2023

NK cells may hold key to link between viral infections, MS

  • MS Research Study and Reports
    /
Multiple risk factors, antibodies against EBV and myelin lead to high MS riskby Marisa Wexler, MS | December 15, 2023…
MS Research Study and Reports

December 21, 2023

Neurofilament Light Chain Assay

  • MS BIOMARKERS
    /
 Advance your neurology research from discovery to diagnostics by reliably measuring neurofilament light (NfL). The Quanterix Simoa® NfL Assay is…
MS BIOMARKERS

December 20, 2023

New study suggests possible targets for multiple sclerosis vaccine development

  • MS Research Study and Reports
    /
 Published December 15, 2023 | Originally published on MedicalXpress Breaking News-and-Events Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr…
MS Research Study and Reports

December 19, 2023

Cognitive Behavioral Therapy for Reducing Depressive Symptoms in Multiple Sclerosis

  • Multiple Sclerosis (MS) Symptoms
    /
  A remote-access internet-delivered cognitive behavioral therapy program was found to be safe and effective for alleviating the symptoms of…
Multiple Sclerosis (MS) Symptoms

December 14, 2023

U.S. Neurologists Eagerly Await Promising Oral BTKis in MS Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 Efficacy and safety of pipeline multiple sclerosis assets viewed as increasingly important characteristics, according to Spherix Global Insights.  [Exton PA, December 13,…
MS Drug Therapies

December 14, 2023

Multiple Sclerosis and Diet: All You Need to Know

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Nutrition
    /
 Multiple sclerosis (MS) is one of the most common neurological disorders. It affects almost 914,000 U.S. adults and over 2.1…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

December 14, 2023

Regular exercise plays a pivotal role in enhancing the lives of individuals diagnosed with Multiple Sclerosis

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 Regular exercise plays a pivotal role in enhancing the lives of individuals diagnosed with Multiple Sclerosis (MS). While facing the…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

December 14, 2023

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis

  • MS Research Study and Reports
    /
 Abstract Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used.…
MS Research Study and Reports

Categories

Latest Blog Posts